Dynasore: Noncompetitive Dynamin GTPase Inhibitor for Endocytosis Research

Executive Summary: Dynasore is a cell-permeable, noncompetitive inhibitor of dynamin GTPase, exhibiting an IC50 of 15 μM under standard in vitro assay conditions (APExBIO). It blocks dynamin-dependent endocytosis, including transferrin uptake and synaptic vesicle recycling, in diverse cell types (Zheng et al., 2024). The compound is insoluble in water and ethanol but highly soluble in DMSO (≥16.12 mg/mL), requiring stock preparation in DMSO and storage at -20°C. Dynasore is validated for studies of vesicle trafficking pathways relevant to cancer, neurodegenerative disease, and host-microbiome interactions (internal source). APExBIO supplies Dynasore (SKU: A1605) for research use only.

Biological Rationale

Endocytosis is a fundamental process enabling cells to internalize extracellular molecules and membrane proteins. Dynamin GTPases (dynamin1, dynamin2, and Drp1) are central to vesicle scission during clathrin-mediated and other forms of endocytosis (Zheng et al., 2024). These enzymes hydrolyze GTP, facilitating membrane fission, vesicle trafficking, and downstream signal transduction. Dysregulation of dynamin-mediated pathways is implicated in cancer progression, neurodegeneration, and infectious disease (internal source). In particular, extracellular vesicles (EVs) shed by microbes such as Fusobacterium nucleatum have been shown to exploit host endocytic machinery to colonize tumor tissue, highlighting the need for precise inhibitors like Dynasore in mechanistic studies (Zheng et al., 2024).

Mechanism of Action of Dynasore

Dynasore acts as a noncompetitive inhibitor of dynamin GTPase activity. It binds outside the GTP-binding pocket, allosterically suppressing GTP hydrolysis by dynamin1, dynamin2, and Drp1 (APExBIO). The compound exhibits rapid onset and reversible effects, allowing temporal control over dynamin-dependent processes. By inhibiting GTPase activity, Dynasore prevents the membrane fission step required for the release of nascent endocytic vesicles. This blockade leads to the accumulation of clathrin-coated pits and a marked decrease in transferrin and synaptic vesicle uptake (internal source). Unlike competitive inhibitors, Dynasore does not compete with GTP, minimizing off-target interactions in nucleotide-rich cellular environments.

Evidence & Benchmarks

• Dynasore inhibits dynamin1/2 GTPase activity with an IC50 of 15 μM in vitro (APExBIO, product page).
• It blocks transferrin uptake in HL-1 cells within 10 minutes of exposure at 80 μM, confirming rapid, reversible inhibition (Zheng et al., 2024, DOI).
• The compound inhibits synaptic vesicle endocytosis in neurons, as measured by FM dye uptake and electrophysiological assays (internal source).
• Dynasore’s action is reversible upon washout, enabling time-resolved studies of endocytic trafficking (APExBIO, product page).
• In cancer models, Dynasore impedes the uptake of microbial EVs by tumor cells, supporting its utility in host-pathogen interaction studies (Zheng et al., 2024, DOI).

This article expands on insights from Dynasore in Cancer and Microbiome Research by providing updated benchmarks and contextualizing Dynasore’s role in bacterial EV-host interactions, as described in recent peer-reviewed work.

For a comprehensive analysis of translational strategies and mechanistic underpinnings, see Translational Strategies for Targeting Vesicle Trafficking. This present article places greater emphasis on evidence from colorectal cancer microbiome studies and practical workflow integration.

Applications, Limits & Misconceptions

Dynasore is widely used to dissect vesicle trafficking and endocytic pathways in cellular, cancer, and neurodegenerative disease models. Its noncompetitive, reversible inhibition enables dynamic studies of signal transduction, protein biosynthesis, and membrane protein translocation. Recent research demonstrates its value in exploring the uptake of bacterial EVs and the modulation of the tumor microenvironment (Zheng et al., 2024).

Common Pitfalls or Misconceptions

• Dynasore is not effective against endocytosis pathways independent of dynamin GTPase (e.g., caveolin-independent routes).
• It does not distinguish between dynamin isoforms in mixed cell populations—interpretation requires appropriate controls.
• High concentrations (>100 μM) may induce cytotoxicity in sensitive cell lines; dose optimization is essential.
• Dynasore is insoluble in water and ethanol; improper solvent selection can cause precipitation and loss of activity.
• It is not suitable for in vivo diagnostic or therapeutic applications; research use only as specified by APExBIO.

For further detail on how Dynasore compares to other inhibitors and expands analytical frameworks for cancer biology, see Dynasore: Unlocking Vesicle Trafficking Pathways in Cancer. This article updates that discussion with evidence from the latest microbiome-cancer research.

Workflow Integration & Parameters

• Solubility: Dynasore is soluble in DMSO at ≥16.12 mg/mL; insoluble in water and ethanol (APExBIO).
• Stock Preparation: Dissolve in DMSO, warm to 37°C or sonicate to increase solubility, filter if necessary.
• Storage: Stock solutions and dry powder are stable at -20°C for several months. Minimize freeze-thaw cycles.
• Working Concentrations: Typical experimental concentrations range from 20 μM to 100 μM, depending on cell type and endpoint.
• Controls: Always include DMSO vehicle controls and, where possible, use isoform-specific dynamin knockdowns to confirm specificity.

For product specifications and ordering, visit the official APExBIO Dynasore (A1605) page.

Conclusion & Outlook

Dynasore is a validated, versatile tool for inhibiting dynamin GTPase activity in cell-based models, enabling rigorous investigation of endocytosis, vesicle trafficking, and host-microbiome interactions. Its rapid, reversible action and well-characterized properties facilitate reproducible workflows in cancer, neurobiology, and translational research. Ongoing studies continue to reveal new applications in the modulation of microbial EV uptake and tumor microenvironment engineering (Zheng et al., 2024). For precise, reliable results, strict adherence to solvent and storage guidelines is recommended. APExBIO remains a leading supplier of research-grade Dynasore (A1605) for the global scientific community.